Status:
WITHDRAWN
High Or Low Dose pOstpartUm Oxytocin at the Time of Cesarean Birth
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Medical College of Wisconsin
Conditions:
Postpartum Hemorrhage
Pregnancy Complications
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
This is a study to investigate whether it is feasible to conduct a randomized controlled trial (RCT) of a high dose of oxytocin versus the standard low-dose oxytocin. Further the investigators, aim to...
Detailed Description
Due to risks of postpartum hemorrhage, defined by the American College of Obstetricians and Gynecologists, as an estimated or quantitative blood loss of greater than 1000 milliliters, uterotonics, or ...
Eligibility Criteria
Inclusion
- Inclusion criteria.
- Age 18 or greater
- English or Spanish speaking
- Individuals undergoing a scheduled or unscheduled cesarean delivery
- Exclusion criteria
- Patient on therapeutic anticoagulation
- Patient with hypertensive disorder of pregnancy or chronic hypertension
- Patient with preexisting bleeding disorder
- Patient with preexisting cardiac disease
- Patient with severe asthma, defined as the need for two or more agents for disease control, or bronchospasm
- Patient undergoing planned cesarean hysterectomy
Exclusion
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06550089
Start Date
October 1 2024
End Date
December 1 2026
Last Update
December 10 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.